RPG Life Sciences Share Price
2720.10+67.70 (+2.55%)
+14.81% past 1 Year
RPG Life Sciences a part of RPG Enterprises is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations Global Generics and Synthetic APIs space.
Corporate filings & documents
Announcements
Update on Analyst/Institutional call
7 hours agoIntimation of Investor meet dial in details
1 day agoIntimation of Investor meet dial in details
1 day agoInvestors Presentation
1 day agoInvestors Presentation
1 day agoSchedule of Investors Meet
1 day agoSchedule of Investors Meet
1 day agoPress Release
1 day agoPress Release
1 day agoIntimation of execution of Business Transfer Agreement by RPG Active Pharma Limited (WOS) with Raghava Life Sciences Private Limited for Acquisition of API Business.
1 day agoIntimation of execution of Business Transfer Agreement by RPG Active Pharma Limited (WOS) with Raghava Life Sciences Private Limited for Acquisition of API Business.
1 day agoOutcome of Board Meeting
1 day agoOutcome of Board Meeting
1 day agoCancellation of Investor meet
2 days agoThe Company has informed about the Schedule of Analyst/Institutional Investors Meet
1 week agoThe Company has informed about the Schedule of Analyst/Institutional Investors Meet
1 week agoThe Company has informed about the Schedule of Analyst/Institutional Investors Meet
2 weeks agoThe Company has informed about the Schedule of Analyst/Institutional Investors Meet
2 weeks agoResignation of Senior Management Personnel
2 weeks agoCompletion of transactions in API Business Transfer Agreement with RPG Active Pharma Limited.
2 weeks agoRPG Life Sciences Limited has informed the Exchange about the Further investment in RPG Active Pharma Limited
2 weeks agoPursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the details of the Analyst/Institutional Investors meet to be attended by the Company are enclosed.
3 weeks agoPursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the details of the Analyst/Institutional Investors meet to be attended by the Company are enclosed.
3 weeks agoIntimation on superannuation of Senior Management Personnel
1 month agoNewspaper advertisement in respect to Special window opened for lodgement of transfer and dematerialization request(s).
1 month agoNewspaper advertisement in respect to Special window opened for lodgement of transfer and dematerialization request(s).
1 month agoPress Release
1 month agoExecution of Share Purchase Agreement
1 month agoExecution of Business Transfer Agreement
1 month agoOutcome of Board Meeting held today July 29 2026
1 month agoCopy of Newspaper Publication
1 month agoCopy of Newspaper Publication
1 month agoInvestor Presentation
1 month agoInvestor Presentation
1 month agoPress release
1 month agoPress release
1 month agoUnaudited consolidated and standalone Financial Results for quarter ended June 2026
1 month agoUnaudited consolidated and standalone Financial Results for quarter ended June 2026
1 month agoOutcome of Board meeting
1 month agoOutcome of Board meeting
1 month agoCompletion of term of Ms. Zahabiya Khorakiwala
1 month agoCompletion of term of Ms. Zahabiya Khorakiwala
1 month agoVoting Results along with a copy of Scrutinizers Report
1 month ago19th AGM Proceedings
1 month agoRPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday July 28 2026 inter-alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026 and to take on record the Limited Review Report thereon.
1 month agoRPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday July 28 2026 inter-alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026 and to take on record the Limited Review Report thereon.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018
1 month agoPress release with respect to Naprosyn ES Launch
1 month agoPress release with respect to Naprosyn ES Launch
1 month agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Oct 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Apr 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Jul 2024
ConcallPresentation
Apr 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Oct 2023
ConcallPresentation
Jul 2023
ConcallPresentation
May 2023
ConcallPresentation
Apr 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Oct 2022
ConcallPresentation
Oct 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Apr 2022
ConcallPresentation
Jan 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Oct 2021
ConcallPresentation
Apr 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-09
Dividend
24.0
2025-06-27
Dividend
4.0
2025-06-27
Dividend
20.0
2024-06-28
Dividend
16.0
2023-07-21
Dividend
12.0
2022-07-14
Dividend
9.6
2021-08-13
Dividend
7.2
2020-03-24
Dividend
4.0
2019-07-22
Dividend
2.4
2018-07-19
Dividend
2.4
2017-07-13
Dividend
2.8
2016-03-22
Dividend
1.6
2015-07-20
Dividend
0.8
2014-09-11
Dividend
2.0
2013-07-11
Dividend
1.2
2012-07-24
Dividend
0.8
2011-07-14
Dividend
1.6
2010-07-15
Dividend
1.44
Company details
Registered office
R P G House , 463 Ceat Mahal Dr. Annie Besant Road, Worli Mumbai Maharashtra PIN: 400030 Tel No: 022 - 24981650 / 24986375 Fax No: 022 - 24970127 Email: [email protected] Internet: www.rpglifesciences.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Harsh Goenka, Chairman
Ashok Nair, Managing Director
Hiten Kotak, Non Executive Independent Director
Bhaskar Iyer, Non Executive Independent Director
Anil Matai, Non Executive Independent Director
Radhika Gupta, Non Executive Independent Director
Sachin Nandgaonkar, Non Executive Independent Director
Vasundhara Patni, Non Executive Director
Manoj K Maheshwari, Non Executive Director
Yugal Sikri, Non Independent & Non Executive Director
Rajesh Shirambekar, Head - Legal, Company Secretary & Compliance Officer
Pratit Samdani, Non Executive Independent Director
Details
BSE 532983
NSE RPGLIFE
ISIN INE105J01010